Correlation Between Genmab AS and Dataproces Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Dataproces Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Dataproces Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Dataproces Group AS, you can compare the effects of market volatilities on Genmab AS and Dataproces Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Dataproces Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Dataproces Group.

Diversification Opportunities for Genmab AS and Dataproces Group

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Genmab and Dataproces is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Dataproces Group AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dataproces Group and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Dataproces Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dataproces Group has no effect on the direction of Genmab AS i.e., Genmab AS and Dataproces Group go up and down completely randomly.

Pair Corralation between Genmab AS and Dataproces Group

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Dataproces Group. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.2 times less risky than Dataproces Group. The stock trades about -0.07 of its potential returns per unit of risk. The Dataproces Group AS is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  585.00  in Dataproces Group AS on September 18, 2024 and sell it today you would earn a total of  10.00  from holding Dataproces Group AS or generate 1.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Dataproces Group AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Dataproces Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dataproces Group AS are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Dataproces Group displayed solid returns over the last few months and may actually be approaching a breakup point.

Genmab AS and Dataproces Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Dataproces Group

The main advantage of trading using opposite Genmab AS and Dataproces Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Dataproces Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dataproces Group will offset losses from the drop in Dataproces Group's long position.
The idea behind Genmab AS and Dataproces Group AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated